Toxic epidermal necrolysis Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis

被引:121
作者
Schwartz, Robert A. [1 ]
McDonough, Patrick H. [1 ]
Lee, Brian W. [1 ]
机构
[1] Rutgers State Univ, Sch Med, Newark, NJ 07103 USA
关键词
apoptosis; drug eruption; erythema multiforme; granulysin; Stevens-Johnson syndrome; toxic epidermal necrolysis; STEVENS-JOHNSON-SYNDROME; CUTANEOUS ADVERSE-REACTIONS; NITRIC-OXIDE SYNTHASE; ERYTHEMA MULTIFORME; T-CELLS; HLA-B-ASTERISK-1502; ALLELE; HLA-B; HYPERSENSITIVITY REACTIONS; KERATINOCYTE DEATH; EFFECTOR-CELLS;
D O I
10.1016/j.jaad.2013.05.003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Toxic epidermal necrolysis is a life-threatening, typically drug-induced mucocutaneous disease. It is clinically characterized as a widespread sloughing of the skin and mucosa, including both external and internal surfaces. Histologically, the denuded areas show full thickness epidermal necrosis. The pathogenic mechanism involves antigenic moiety/metabolite, peptide-induced T cell activation, leading to keratinocyte apoptosis through soluble Fas ligand, perforin/granzyme B, tumor necrosis factor-alfa, and nitric oxide. Recent studies have implicated granulysin in toxic epidermal necrolysis apoptosis and have suggested that it may be the pivotal mediator of keratinocyte death.
引用
收藏
页码:173.e1 / 173.e13
页数:13
相关论文
共 117 条
  • [1] Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand
    Abe, R
    Shimizu, T
    Shibaki, A
    Nakamura, H
    Watanabe, H
    Shimizu, H
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) : 1515 - 1520
  • [2] Toxic epidermal necrolysis and Stevens-Johnson syndrome: Soluble Fas ligand involvement in the pathomechanisms of these diseases
    Abe, Riichiro
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 52 (03) : 151 - 159
  • [3] Granulysin as a Marker for Early Diagnosis of the Stevens-Johnson Syndrome
    Abe, Riichiro
    Yoshioka, Naoya
    Murata, Junko
    Fujita, Yasuyuki
    Shimizu, Hiroshi
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (07) : 514 - 515
  • [4] ERYTHEMA MULTIFORME EXUDATIVUM MAJOR (STEVENS-JOHNSON SYNDROME)
    ALEXANDER, MK
    COPE, S
    [J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1954, 68 (02): : 373 - +
  • [5] [Anonymous], 1995, NATURE
  • [6] ERYTHEMA MULTIFORME WITH MUCOUS-MEMBRANE INVOLVEMENT AND STEVENS-JOHNSON SYNDROME ARE CLINICALLY DIFFERENT DISORDERS WITH DISTINCT CAUSES
    ASSIER, H
    BASTUJIGARIN, S
    REVUZ, J
    ROUJEAU, JC
    [J]. ARCHIVES OF DERMATOLOGY, 1995, 131 (05) : 539 - 543
  • [7] TOXIC EPIDERMAL NECROLYSIS - A REVIEW
    AVAKIAN, R
    FLOWERS, FP
    ARAUJO, OE
    RAMOSCARO, FA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (01) : 69 - 79
  • [8] Baldwin BT, 2010, J DRUGS DERMATOL, V9, P837
  • [9] Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: Reports to the vaccine adverse event reporting system
    Ball, R
    Ball, LK
    Wise, RP
    Braun, MM
    Beeler, JA
    Salive, ME
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (02) : 219 - 223
  • [10] CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME
    BASTUJIGARIN, S
    RZANY, B
    STERN, RS
    SHEAR, NH
    NALDI, L
    ROUJEAU, JC
    [J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (01) : 92 - 96